Cargando…
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]
Autores principales: | Idrus, Hasta Handayani, Sunarno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910095/ https://www.ncbi.nlm.nih.gov/pubmed/36776449 http://dx.doi.org/10.2147/DDDT.S405817 |
Ejemplares similares
-
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
por: Han, Xue, et al.
Publicado: (2022) -
Evaluation of the Performance of a Multiplex Real-Time PCR Assay for the Identification of Aspergillus, Cryptococcus neoformans, and Pneumocystis jirovecii Simultaneously from Sputum in Multicenter [Letter]
por: Idrus, Hasta Handayani, et al.
Publicado: (2022) -
Detection of Antibiotic Resistance Genes in Pseudomonas aeruginosa by Whole Genome Sequencing [Letter]
por: Idrus, Hasta Handayani, et al.
Publicado: (2022) -
Senescent Cardiac Fibroblast Is Critical for Cardiac Fibrosis after Myocardial Infarction
por: Zhu, Fuli, et al.
Publicado: (2013) -
The Effects of Physical Activity on Health-Related Quality of Life Among Working Mothers Living in Amman: A Correlational Study [LETTER]
por: Febriza, Ami, et al.
Publicado: (2023)